Shares of vaccine companies such as Moderna (MRNA), Pfizer (PFE) and BioNTech (BNTX), among others, are falling after a ...
The quarter saw Regeneron grow its revenue by 10% year over year to just under $3.79 billion. Although non-GAAP (adjusted) ...
Market uncertainty makes investors nervous about investing in speculative industries. But Wall Street has high hopes for ...
Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued ...
Vertex Pharmaceuticals ( VRTX 2.53%) has long been known as the company to turn to for life-saving cystic fibrosis (CF) drugs ...
Biotech investing can be tricky. Often, the drugs that these fledgling companies produce don’t pan out, and shareholders take ...
Argus has a “buy” rating and $185 price target for JNJ stock, which closed at $146.64 on Jan. 23. AbbVie is a global pharmaceutical company. Its key drugs include Humira for treating ...
Learn more about whether Arrowhead Pharmaceuticals, Inc. or Veracyte, Inc. is a better investment based on AAII's A+ Investor ...
Cumberland Pharmaceuticals, Inc. (CPIX) stock saw a modest uptick, ending the day at $3.76 which represents a slight increase of $1.63 or 76.53% from the prior close of $2.13. The stock opened at ...
Tonix Pharmaceuticals (TNXP) stock plunged after the company carried out a 1-for-100 reverse stock split as it awaits approval for its ...
Shares of Vertex Pharmaceuticals Inc. surged ahead of Friday’s market open after the Food and Drug Administration approved ...
Pharmaceutical company Sigachi Industries shares are in action today as the company announced to establish a state-of-the-art ...